A price-to-book ratio sitting at roughly 1.0x places NuScale Power (NASDAQ: SMR) well below both its sector peers and the broader Electrical industry, raising pointed questions about whether a discount or a trap awaits investors.
The wider Electrical industry trades at approximately 2.0x book value on average, while a closer peer group commands multiples nearer to 4.8x, making NuScale’s current pricing look conspicuously cheap by comparison.
That discount has emerged after a punishing 12 months in which the small modular reactor developer’s shares have shed 86.5% of their value, wiping out most of what investors paid at the start of the period.
For a company that has yet to generate revenue, the book value lens matters more than usual because the balance sheet is dominated by a cash reserve and intellectual property rather than operating earnings.
NuScale reported liquidity of approximately US$1.9 billion, a figure that anchors the bull argument that the business has time and resources to convert engineering progress into commercial contracts.
A manufacturing agreement with South Korean industrial group Doosan Enerbility (KRX: 034020.KS) to produce key reactor module components has been cited as evidence that the company is closing the gap between design and physical production.
Despite that deal, the market continues to assign NuScale a valuation close to the net asset floor, suggesting investors remain unconvinced that project contracts will materialize at the pace or scale needed to justify a richer multiple.
The divide between optimists and skeptics is stark, with one analytical framework putting the stock at 51% undervalued while an opposing view describes it as 533% overvalued, a spread that reflects deep uncertainty about execution.
The bull case hinges on a specific condition, with proponents arguing that “the main requirement for this view is converting regulatory progress, liquidity of about US$1.9b and advanced supplier manufacturing into firm long-term power purchase and project contracts.”
The bear camp points to legal exposure as the more pressing concern, warning that “the ENTRA1 controversy and the resulting fraud lawsuits are serious,” and questioning whether management can deliver commercially as effectively as it has on the engineering side.
Beyond the valuation debate, analysts covering the stock have flagged at least one major warning sign alongside two additional red flags that prospective investors should weigh before treating the low P/B ratio as a straightforward entry signal.
NuScale sits within a broader universe of 16 publicly listed nuclear energy infrastructure stocks, a group that offers context for how the market is pricing different stages of the reactor development cycle.
The central judgment for any investor considering the stock comes down to whether the gap between NuScale’s 1.0x book multiple and its peer group’s 4.8x reflects legitimate concerns about contract risk and legal overhangs, or whether the cash-heavy balance sheet is simply being mispriced by a market still digesting the share price collapse.
